Brown-Forman Form 4: CFO gets 75k stock appreciation rights
Rhea-AI Filing Summary
Brown-Forman (BF) filed a Form 4 disclosing that EVP & CFO Leanne D. Cunningham received a stock appreciation right (SAR) covering 75,105 Class B shares on 07/24/2025. The SAR carries an exercise price of $31.15, becomes exercisable on 05/01/2028, and expires on 04/30/2035. No common shares were bought or sold; the filing records only the new derivative grant. After the award, Cunningham directly holds 75,105 derivative securities and no change is reported for her non-derivative ownership. The transaction appears to be routine long-term incentive compensation and does not materially affect Brown-Forman’s share count or control structure.
Positive
- Equity-based incentive aligns CFO interests with shareholders
- No insider selling; signals management retention and stability
Negative
- Incremental dilution if SARs are exercised, albeit immaterial
Insights
TL;DR: Routine equity grant; neutral impact, minor dilution risk.
The Form 4 shows a single SAR grant to the CFO, typical for executive incentives. With 75,105 underlying shares (~0.02 % of BF’s ~480 m diluted shares), potential dilution is immaterial. No disposals suggest management confidence and retention. Investors should view the filing as neutral; it neither signals insider buying nor selling.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Appreciation Right | 75,105 | $0.00 | $0.00 |
FAQ
What did Brown-Forman (BF) report in this Form 4?
When can the CFO exercise the SAR?
How large is the potential dilution from this grant?
Does the filing indicate insider sentiment?
AI-generated analysis. How Rhea-AI works. Not financial advice.